Codexis, Inc. - stock earnings
CDXS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | -0.16 / -0.18 | - | 17.1 million / 14.1 million | - |
| Aug. 1, 2024 BeforeMarket | - / - | 9.3 million | - / 12.5 million | 15.2 million |
CDXS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -11.5 million USD | 17.1 million USD |
| 2023Q4 | -7.2 million USD | 26.6 million USD |
| 2023Q3 | -34.9 million USD | 9.3 million USD |
| 2023Q2 | -11.5 million USD | 21.3 million USD |
| 2023Q1 | -22.6 million USD | 13.0 million USD |
| 2022Q4 | -12.6 million USD | 30.4 million USD |
| 2022Q3 | -10.0 million USD | 34.5 million USD |
| 2022Q2 | -2.6 million USD | 38.4 million USD |
| 2022Q1 | -8.4 million USD | 35.3 million USD |
| 2021Q4 | -10.2 million USD | 24.5 million USD |
| 2021Q3 | 2.2 million USD | 36.8 million USD |
| 2021Q2 | -4.3 million USD | 25.5 million USD |
| 2021Q1 | -9.1 million USD | 18.0 million USD |
| 2020Q4 | -3.9 million USD | 21.0 million USD |
| 2020Q3 | -6.1 million USD | 18.4 million USD |
| 2020Q2 | -6.3 million USD | 15.0 million USD |
| 2020Q1 | -7.7 million USD | 14.7 million USD |
| 2019Q4 | -635000 USD | 18.7 million USD |
| 2019Q3 | 343000 USD | 21.9 million USD |
| 2019Q2 | -6.5 million USD | 12.3 million USD |
| 2019Q1 | -5.1 million USD | 15.6 million USD |
| 2018Q4 | -461000 USD | 16.1 million USD |
| 2018Q3 | -2.0 million USD | 16.9 million USD |
| 2018Q2 | -3.7 million USD | 13.5 million USD |
| 2018Q1 | -4.7 million USD | 14.0 million USD |
| 2017Q4 | 970000 USD | 21.7 million USD |
| 2017Q3 | -10.2 million USD | 10.0 million USD |
| 2017Q2 | -6.3 million USD | 10.3 million USD |
| 2017Q1 | -7.5 million USD | 8.0 million USD |
| 2016Q4 | -5.3 million USD | 10.0 million USD |
| 2016Q3 | 1.4 million USD | 14.9 million USD |
| 2016Q2 | 2.2 million USD | 16.0 million USD |
| 2016Q1 | -7.0 million USD | 8.0 million USD |
| 2015Q4 | -2.1 million USD | 11.6 million USD |
| 2015Q3 | 5.4 million USD | 17.4 million USD |
| 2015Q2 | -5.4 million USD | 6.0 million USD |
| 2015Q1 | -5.6 million USD | 6.8 million USD |
| 2014Q4 | 345000 USD | 14.2 million USD |
| 2014Q3 | -4.6 million USD | 7.5 million USD |
| 2014Q2 | -8.5 million USD | 6.6 million USD |
| 2014Q1 | -6.4 million USD | 7.1 million USD |
| 2013Q4 | -9.8 million USD | 9.5 million USD |
| 2013Q3 | -9.3 million USD | 3.9 million USD |
| 2013Q2 | -12.6 million USD | 7.0 million USD |
| 2013Q1 | -15.5 million USD | 7.9 million USD |
| 2012Q4 | -15.5 million USD | 7.9 million USD |
| 2012Q3 | -2.3 million USD | 26.3 million USD |
| 2012Q2 | -5.5 million USD | 22.9 million USD |
| 2012Q1 | -7.5 million USD | 31.1 million USD |
| 2011Q4 | -5.3 million USD | 33.5 million USD |
| 2011Q3 | -2.7 million USD | 33.3 million USD |
| 2011Q2 | -5.0 million USD | 26.1 million USD |
| 2011Q1 | -3.5 million USD | 31.0 million USD |
| 2010Q4 | -494000 USD | 29.8 million USD |
| 2010Q3 | -2.7 million USD | 27.1 million USD |
| 2010Q2 | -3.9 million USD | 24.5 million USD |
| 2010Q1 | -1.4 million USD | 25.7 million USD |
| 2009Q4 | -5.2 million USD | 24.2 million USD |
| 2009Q3 | -6.2 million USD | 20.1 million USD |
| 2009Q2 | -2.9 million USD | 19.2 million USD |
| 2009Q1 | -6.1 million USD | 19.4 million USD |
| 2008Q4 | -6.3 million USD | 18.6 million USD |
| 2008Q1 | -13.9 million USD | 8.4 million USD |
| 2007Q4 | ? USD | 25.3 million USD |
| 2007Q1 | -5.1 million USD | 4.7 million USD |
| 2006Q4 | ? USD | 12.1 million USD |
CDXS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -76.2 million USD | 70.1 million USD |
| 2022 | -33.6 million USD | 138.6 million USD |
| 2021 | -21.3 million USD | 104.8 million USD |
| 2020 | -24.0 million USD | 69.1 million USD |
| 2019 | -11.9 million USD | 68.5 million USD |
| 2018 | -10.9 million USD | 60.6 million USD |
| 2017 | -23.0 million USD | 50.0 million USD |
| 2016 | -8.6 million USD | 48.8 million USD |
| 2015 | -7.6 million USD | 41.8 million USD |
| 2014 | -19.1 million USD | 35.3 million USD |
| 2013 | -41.3 million USD | 31.9 million USD |
| 2012 | -30.9 million USD | 88.3 million USD |
| 2011 | -16.6 million USD | 123.9 million USD |
| 2010 | -8.5 million USD | 107.1 million USD |
| 2009 | -20.3 million USD | 82.9 million USD |
| 2008 | -45.1 million USD | 50.5 million USD |
| 2007 | -39.0 million USD | 25.3 million USD |
| 2006 | -18.7 million USD | 12.1 million USD |
CDXS
Price: $3.50
52 week price:
Earnings Per Share: -1.12 USD
P/E Ratio: -2.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 517700
Ebitda: -9.8 millionMarket Capitalization: 276.6 million